Tirzepatide
Anti-diabetic and weight loss medication
Tirzepatide ▸ Facts ▸ Comments ▸ News ▸ Videos
Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. In the United States, it is sold under the brand name Mounjaro for diabetes treatment and Zepbound for weight loss and treatment of obstructive sleep apnea.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Blockbuster weight loss drug Mounjaro launched, prices starts at Rs 3500 per vialPharma giant Eli Lilly has launched Mounjaro, a popular weight-loss drug, in India. Priced at Rs 3,500 for 2.5 mg and Rs 4,375 for 5 mg, Mounjaro is available by prescription and aims to address..IndiaTimes - Published | |
Weight loss drug gets US nod to treat sleep apnea; India launch likely next yearThe US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending approvals...IndiaTimes - Published |
| Search this site and the web: |
